4th Quarter - Report

VIZIENT, INC. for VIZIENT INC

Firm
Client
Income
—
Expenses
$160,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

COVID-19 crisis - Engaged with Congress and the administration to advocate for greater regulatory flexibility and appropriate reimbursement for hospitals through development, passage and ongoing implementation of coronavirus relief legislation: HEROES Act (H.R. 6800) Heroes Act 2.0 (H.R. 925) Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 178) The Consolidated Appropriations Act (H.R. 133) Hospital Provider Relief Fund - Urged Congress to provide additional funding for the Provider Relief Fund. Advocated in Congress and with HHS to revert to initial June guidance defining "lost revenue". Liability protections - Advocated for Congress to include liability protections for health care workers and facilities responding to the COVID-19 crisis. Front-line Health Care Worker Hazard Pay - Advocated for Congress to provide funding to enhance payment for essential health care workers. Hospital Group Purchasing - Offered recommendations and insights to support access to essential personal protective equipment, medications and supplies for hospitals treating patients and supply chain stability for the national response to the COVID-19 crisis. 340B Drug Pricing Program - Urged HHS to act to enforce guidance regarding 340B discounts through contract pharmacies. Vaccine distribution, administration and communications - Advocated to provide states with financial support and other resources to enhance communications and for transparency, including support regarding vaccine distribution, administration and post-market processes, considering both providers needs and states needs. Surprise Billing - Supported inclusion of provisions to provide for an independent dispute resolution process in legislation to address surprise bills (H.R. 3630; H.R. 2328; S. 1895; H.R. 133). Urged Congress to oppose benchmark payment rates in COVID relief legislation. Advocated for passage of the Pasteur Act (S. 4760; H.R. 8920)

LobbyistCovered position, as disclosed
SHOSHANA KRILOW —
STEVEN RIXEN —
JENNA STERN —

Contacted: Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: H.R. 925 (116th), H.R. 3630 (116th), S. 1895 (116th), H.R. 2328 (116th), H.R. 8920 (116th), H.R. 6800 (116th), H.R. 133 (116th), S. 4760 (116th), S. 178 (116th)

Medicare/Medicaid MMM

COVID-19 crisis - Engaged with Congress and the administration to advocate for greater regulatory flexibility and appropriate reimbursement for hospitals through development, passage and ongoing implementation of coronavirus relief legislation: HEROES Act (HR 6800) Heroes Act 2.0 (H.R. 925) Health, Economic Assistance, Liability Protection and Schools (HEALS) Act (S. 178) The Consolidated Appropriations Act (H.R. 133) Telehealth - Urged Congress and the administration to make permanent telehealth flexibilities related to distant site and geographic limitations, expanding provider types and services available to consumers and maintain Medicare reimbursement parity. Accelerated and Advanced Payment Program - Advocated for Congress and the administration to offer forgiveness for accelerated and advanced payments during the COVID-19 public health emergency. Offered support for reduced interest rates, extended loan repayment period and reduced recoupment amounts (S. 3750/H.R. 6837/ H.R. 8337 / H.R. 133). Medicaid Disproportionate Share Hospital (DSH) Payments - Urged Congress to end or further delay implementation of Medicaid DSH payment cuts. Medicare Sequester - urged Congress to end or further delay ongoing Medicare sequestration reimbursement reductions. Enhanced Federal Medical Assistance Percentage (FMAP) - Urged Congress to extend the increased Medicaid FMAP matching rate beyond the public health emergency and increase the enhanced percentage. Medicaid Fiscal Accountability Regulation - Urged CMS to permanently withdraw the Medicaid Fiscal Accountability Regulation and advocated for Congress to rescind the proposal. COVID-19 Data Reporting Requirements for Hospitals - Urged HHS ease burden of COVID-19 mandatory reporting requirements and clarify aspects of reporting. Resident Physician Shortage Reduction Act (S. 348) - Urged Congress to pass the Resident Physician Shortage Reduction Act. Most Favored Nation - Urged CMS to withdraw or delay the start of the Most-Favored Nation regulation for drug reimbursement for hospitals and other providers.

LobbyistCovered position, as disclosed
SHOSHANA KRILOW —
STEVEN RIXEN —
JENNA STERN —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 348 (116th), H.R. 6800 (116th), S. 178 (116th), H.R. 133 (116th), H.R. 8337 (116th), H.R. 925 (116th), H.R. 6837 (116th), S. 3750 (116th)

Tariff (miscellaneous tariff bills) TAR

Urged the USTR to extend exclusions for Sec. 301 tariffs until the end of the COVID-19 Public Health Emergency.

LobbyistCovered position, as disclosed
SHOSHANA KRILOW —
STEVEN RIXEN —
JENNA STERN —

Contacted: U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.